125 related articles for article (PubMed ID: 37796197)
1. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
3. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
4. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
5. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
Mettlin CJ; Menck HR; Winchester DP; Murphy GP
Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
8. Unveiling SEER-CAHPS®: a new data resource for quality of care research.
Chawla N; Urato M; Ambs A; Schussler N; Hays RD; Clauser SB; Zaslavsky AM; Walsh K; Schwartz M; Halpern M; Gaillot S; Goldstein EH; Arora NK
J Gen Intern Med; 2015 May; 30(5):641-50. PubMed ID: 25586868
[TBL] [Abstract][Full Text] [Related]
9. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.
Elkin EB; Ishill N; Riley GF; Bach PB; Gonen M; Begg CB; Schrag D
J Natl Cancer Inst; 2008 Jul; 100(14):1013-21. PubMed ID: 18612131
[TBL] [Abstract][Full Text] [Related]
10. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
Lin CC; Virgo KS
Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
[TBL] [Abstract][Full Text] [Related]
12. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
15. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry.
Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB
J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070
[TBL] [Abstract][Full Text] [Related]
17. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
18. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
